台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.50%
  • 成交量
    63
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-華南永昌-嘉義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-嘉義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/170.4106.0000.00105.500.41520.26%
2024/05/140.1101.0000.00102.000.11440.07%
2024/05/130.2107.000.2107.00107.000127-0.02%
2024/04/160.1114.0000.00114.000.11110.05%
2024/04/110.6119.500119.50119.500.61010.59%
2024/04/100.1126.0000.00127.000.1950.10%
2024/04/0900.000.5124.00124.00-0.577-0.65%
2024/04/020124.0000.00123.500700.00%
2024/03/250124.0000.00124.000620.01%
2024/03/202122.0000.00121.502563.54%
2024/03/050112.5000.00113.500330.09%
2024/02/270.1112.5000.00112.500.1320.31%
2024/02/260.1113.0000.00112.000.1320.31%
2024/02/220.1112.5000.00112.000.1320.31%
2024/01/250.1111.0000.00110.500.1300.33%
2024/01/090.1112.0000.00112.500.1270.18%
2023/11/0200.000.1114.50115.00-0.120-0.50%
2023/10/1700.000.3117.50117.00-0.324-1.38%
2023/10/1600.000.1117.00116.50-0.124-0.29%
2023/10/120.1117.0000.00117.000.1250.20%
2023/10/050.1116.0000.00116.500.1250.20%
2023/07/310.1112.4900.00111.500.1330.15%
2023/07/0400.000.4108.00107.50-0.445-0.87%
2023/06/3000.001108.00109.00-147-2.13%
2023/06/090.1108.002108.00107.50-253-3.65%
2023/06/080.1109.502109.00108.50-1.953-3.55%
2023/06/010108.0000.00108.500550.04%
2023/05/190.1108.0000.00108.500.1550.09%
2023/05/150.1108.0000.00107.500.1550.09%
2023/05/1100.000107.00106.50055-0.02%
2023/05/1000.003106.50107.00-355-5.41%
2023/05/050108.501109.00109.00-153-1.85%
2023/05/0200.001109.00109.00-152-1.90%
2023/04/170110.5000.00109.500510.02%
2023/04/130.2119.5000.00119.500.2470.31%
2023/04/111120.5000.00121.001402.48%
2023/04/100.3120.0000.00120.500.3390.64%
2023/03/1400.001112.00112.00-132-3.08%
2023/03/100114.0000.00112.500340.09%
2023/03/080113.0000.00116.000340.11%
2022/05/130.1102.0000.00102.500.1400.12%
2022/04/150.1126.0000.00124.500.1250.19%
2022/03/080.1124.5000.00123.000.1220.44%
2022/03/030.1126.0000.00126.500.1220.44%
2022/03/020.1126.0000.00126.000.1220.44%
2022/02/170125.0000.00125.000210.05%
2022/01/1000.001126.00125.50-123-4.29%
2021/12/3000.001125.00125.50-129-3.42%
2021/12/0800.001125.00125.50-128-3.45%
2021/12/0200.002126.00125.50-231-6.37%
2021/02/1800.001123.50124.00-128-3.55%
2020/03/3100.00196.2096.00-142-2.37%
2020/03/1000.00199.90100.00-128-3.54%
2020/02/211100.5000.00101.501263.82%
2020/01/2000.001102.00102.00-123-4.27%
2019/12/3100.002102.00102.00-220-9.62%
2019/10/2500.001102.00101.50-122-4.52%
2019/10/181102.0000.00101.501244.11%
2019/08/2200.001101.50102.50-142-2.33%
2019/07/021111.0000.00111.501432.32%
2018/12/1000.001103.00103.00-126-3.77%
2018/12/0600.001103.00102.50-126-3.77%
2018/10/2600.001100.5099.60-130-3.33%
2018/09/170106.5000.00106.500520.05%
2018/09/140.7108.0000.00107.000.7521.29%
2018/09/1100.002104.50105.00-253-3.76%
2018/07/251126.0000.00127.001871.15%
2018/06/011124.0000.00124.0011210.82%
2018/05/112125.0000.00124.5021301.53%
2018/05/0900.001129.00129.00-1127-0.79%
2018/01/1500.001117.00118.00-1114-0.87%
2018/01/1200.001111.00110.00-1104-0.95%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音